corpus.blog
43,479 blogs · 5,502,589 posts Claim your blog
Record · corpus.blog/posts/01a0fff3-44ce-724f-b409-3989ae743742

Hub-and-Spoke Biotechs: BridgeBio

centuryofbio.com · published 16 February 2025

A record is what was published and who pointed at it. The text of the post is not held here: read it at the source, or at its Wayback capture.

Read the post at centuryofbio.com Wayback capture
0blogs citing
First cited
—
Most recent
—
Rank this month
not ranked
External links
66
Words captured
6,875

Cited by

No blog we hold has cited this post yet.

Links from this post

Link
Host
https://substackcdn.com/image/fetch/$s_!2sz8!,f_auto,q_auto:good,fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2Fbfa4c078-d22a-49dd-a41b-a590318a34b8_1232x928.png
substackcdn.com
https://substackcdn.com/image/fetch/$s_!6yni!,f_auto,q_auto:good,fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2Fe0968326-cd5a-4740-85e0-1438cacb7058_900x683.jpeg
substackcdn.com
https://substackcdn.com/image/fetch/$s_!R9fV!,f_auto,q_auto:good,fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2F6cb4603d-7980-4c0a-a341-4aaf5b38bdd5_4000x2251.jpeg
substackcdn.com
https://doi.org/10.1126/science.1198039
doi.org
https://substackcdn.com/image/fetch/$s_!kVk_!,f_auto,q_auto:good,fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2Fbe0ac3f2-47eb-4433-b73f-9ed76d861741_1898x888.png
substackcdn.com
https://investor.bridgebio.com/static-files/5adfc161-8a57-40e3-9b26-39d11d5eb709
investor.bridgebio.com
https://substackcdn.com/image/fetch/$s_!qUTZ!,f_auto,q_auto:good,fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2F8cc9328b-d368-4c00-9cdd-c23173ef2994_1200x742.png
substackcdn.com
https://x.com/tszzl/status/1837997448075387054
x.com
https://doi.org/10.1038/nbt.2374
doi.org
https://www.cc.nih.gov/orcs/ind/what-is-an-ind
cc.nih.gov
https://lifescivc.com/2022/04/biotechs-january-chill-big-drop-in-new-startups/
lifescivc.com
https://substackcdn.com/image/fetch/$s_!QBOh!,f_auto,q_auto:good,fl_progressive:steep/https%3A%2F%2Fbucketeer-e05bbc84-baa3-437e-9518-adb32be77984.s3.amazonaws.com%2Fpublic%2Fimages%2F69282a9d-9e6f-49f7-9d99-d4e29c3ae343_926x410.png
substackcdn.com
https://www.notboring.co/p/gassing-the-miracle-machine
notboring.co
https://blog.spec.tech/p/health-technology-is-weird
blog.spec.tech
https://www.nature.com/articles/s44222-023-00146-1
nature.com
https://www.investopedia.com/ask/answers/052015/what-are-some-historical-examples-debt-securitization.asp
investopedia.com
https://youtu.be/vgqG3ITMv1Q?si=ksKH0MxTVwNx0V83
youtu.be
https://www.science.org/content/blog-post/totally-new-way-finance-drug-discovery
science.org
https://doi.org/10.1038/nrd3857
doi.org
https://www.aeaweb.org/articles?id=10.1257/aer.103.3.406
aeaweb.org
https://cancerx.mit.edu/
cancerx.mit.edu
https://www.lifescienceleader.com/doc/from-aha-moment-to-billion-biopharma-0001
lifescienceleader.com
https://capitalip.com/
capitalip.com
https://www.acsh.org/news/2020/06/11/clinical-trial-success-rates-phase-and-therapeutic-area-14845
acsh.org
https://doi.org/10.1016/j.drudis.2013.11.009
doi.org
https://atelfo.github.io/2023/02/26/pharmaceutical-blockbusters-the-past-present-and-future.html
atelfo.github.io
https://en.wikipedia.org/wiki/Orphan_Drug_Act_of_1983
en.wikipedia.org
https://omim.org/
omim.org
https://substackcdn.com/image/fetch/$s_!2FJb!,f_auto,q_auto:good,fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2F5b2b8e65-b8d2-432b-b276-baf21ccccae1_800x600.png
substackcdn.com
https://doi.org/10.1038/s41586-024-07316-0
doi.org
https://substackcdn.com/image/fetch/$s_!Gnxq!,f_auto,q_auto:good,fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2Fc4ea718c-4345-4bbb-9dfd-4ead5113683a_397x420.png
substackcdn.com
https://www.sec.gov/Archives/edgar/data/1743881/000119312519157100/d613995ds1.htm
sec.gov
https://www.pm-research.com/content/iijpormgmt/51/1/213
pm-research.com
https://substackcdn.com/image/fetch/$s_!p5lw!,f_auto,q_auto:good,fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2Fca63b73c-23bd-4ce7-a48d-dde816292f8a_1912x644.png
substackcdn.com
https://substackcdn.com/image/fetch/$s_!S9hF!,f_auto,q_auto:good,fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2F1ff4239b-aabe-466e-b7de-10b055161381_1168x1778.jpeg
substackcdn.com
https://substackcdn.com/image/fetch/$s_!-axw!,f_auto,q_auto:good,fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2F2e61f2c4-2e95-443f-bfba-790b870fe6db_1222x806.png
substackcdn.com
https://substackcdn.com/image/fetch/$s_!qaAb!,f_auto,q_auto:good,fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2Fd13ebd00-b022-4670-a3a7-a0b90b47f2d4_704x395.jpeg
substackcdn.com
https://substackcdn.com/image/fetch/$s_!Hcn2!,f_auto,q_auto:good,fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2Fe5927d56-5729-474d-b62f-bf6a71a6e634_734x640.png
substackcdn.com
https://www.investopedia.com/articles/stocks/06/biotechvaluation.asp
investopedia.com
https://www.fda.gov/news-events/press-announcements/fda-approves-first-treatment-molybdenum-cofactor-deficiency-type
fda.gov
https://en.wikipedia.org/wiki/Priority_review
en.wikipedia.org
https://www.pfizer.com/news/press-release/press-release-detail/u_s_fda_approves_vyndaqel_and_vyndamax_for_use_in_patients_with_transthyretin_amyloid_cardiomyopathy_a_rare_and_fatal_disease
pfizer.com
https://investor.bridgebio.com/news-releases/news-release-details/bridgebio-announces-consistently-positive-results-phase-3
investor.bridgebio.com
https://substackcdn.com/image/fetch/$s_!TAro!,f_auto,q_auto:good,fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2F58672dec-db28-4b0c-af0e-b67422d08524_1628x676.png
substackcdn.com
https://www.biopharmadive.com/news/bridgebio-attruby-acoramidis-fda-approval-attr-cardiomyopathy/733779/
biopharmadive.com
https://www.mckinsey.com/industries/life-sciences/our-insights/small-but-mighty-priming-biotech-first-time-launchers-to-compete-with-established-players
mckinsey.com
https://investor.bridgebio.com/news-releases/news-release-details/bridgebio-announces-commercial-progress-program-updates-and-2025
investor.bridgebio.com
https://www.fiercebiotech.com/biotech/bridgebio-taps-vcs-200m-fueling-oncology-offshoots-push-surpass-kras-class
fiercebiotech.com
https://www.biopharmadive.com/news/gondolabio-bridgebio-spinout-viking-neil-kumar/724820/
biopharmadive.com
https://substackcdn.com/image/fetch/$s_!rhup!,f_auto,q_auto:good,fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2F6a918ead-0f3d-4ebb-9ebe-0207a6eac951_2032x980.png
substackcdn.com
https://investor.bridgebio.com/static-files/9ba7dbbb-4b0a-419a-affa-0f87856d88dd
investor.bridgebio.com
https://www.fiercehealthcare.com/regulatory/senate-confirms-rfk-jr-head-hhs-52-48-vote
fiercehealthcare.com
https://www.wsj.com/health/pharma/the-drug-industry-is-having-its-own-deepseek-moment-68589d70
wsj.com
https://www.nature.com/articles/nbt.2374
nature.com
https://investor.bridgebio.com/static-files/58fcaabe-32dd-4c3a-9928-2b066ddf3e0b
investor.bridgebio.com
https://www.fiercebiotech.com/biotech/bridgebio-s-baffling-heart-disease-drug-fail-de-intensifies-competition-and-net-neutral-for
fiercebiotech.com
https://www.biopharmadive.com/news/bridgebio-acoramidis-attr-cardiomyopathy-trial-results-success/687950/
biopharmadive.com
https://www.fiercepharma.com/pharma/jpm25-after-bridgebio-touts-remarkable-early-uptake-its-vyndaqel-rival-analysts-hail
fiercepharma.com
https://www.fiercepharma.com/pharma/hub-and-spokes-biotech-bridgebio-scores-first-fda-approval-alexion-castoff
fiercepharma.com
https://www.fiercepharma.com/pharma/bridgebio-keeps-fda-approval-spree-rolling-time-nod-for-target-bile-duct-cancer-med
fiercepharma.com
https://www.fiercebiotech.com/biotech/bridgebio-scraps-plan-to-buy-eidos-after-bids-rebuffed
fiercebiotech.com
https://www.thestreet.com/investing/eidos-takeover-bid-glaxo
thestreet.com
https://news.bloomberglaw.com/esg/bridgebio-wins-appeal-over-eidos-deal-ending-pension-fund-suit
news.bloomberglaw.com
https://youtu.be/rWRbTnE1PEM?si=-WntohqexO438Usd
youtu.be
https://www.statnews.com/2025/02/07/nih-slashes-indirect-costs-on-all-grants-to-15-percent-trump/
statnews.com
https://www.statnews.com/2025/02/11/judge-orders-nationwide-halt-trump-nih-research-indirect-costs/
statnews.com
Elsewhere on centuryofbio.com (6)